Microneedle-mediated delivery of DNA and mRNA therapeutics for cancer immunotherapy: advances, design strategies and translational challenges
Rather than treating MNs as a universal replacement for systemic delivery, this review position them as a route-specific platform whose clinical value will depend on rational cargodevice matching, standardized potency testing, and validation in translational models.
Haowei Liu, Qiong Yi, Ling Mei et al.
· NANO · 0 citations